Picard Charlotte, Decrequy Anne, Guenet David, Bursztejn Anne Claire, Toledano Daniel, Richard Nicolas, Kottler Marie-Laure
Service de Génétique, Centre de Référence des Maladies Rares du Métabolisme du Calcium et du Phosphore, CHU de Caen, Caen, France.
Horm Res Paediatr. 2015;83(2):111-7. doi: 10.1159/000369492. Epub 2015 Jan 9.
Hypothyroidism is a particular condition observed in pseudohypoparathyroidism (PHP), a rare disorder characterized by parathyroid (PTH) resistance leading to hypocalcemia and hyperphosphatemia associated with a GNAS (guanine nucleotide-binding protein α-subunit) mutation (PHP1A) or epimutation (PHP1B). To determine the presence of hypothyroidism at birth we conducted a retrospective study in our cohort of patients presenting with either PHP1A (n = 116) or PHP1B (n = 99). We also investigated patients presenting at birth with congenital hypothyroidism (CH) and a eutopic thyroid gland for phosphocalcium abnormalities suggesting PTH resistance and PHP. Our study reveals CH as the earliest diagnostic clue for PHP1A, but not for PHP1B. We estimated the frequency of CH at birth to be between 8 and 34% in patients presenting with PHP1A. The elevation of phosphatemia and PTH concentration precedes hypocalcemia in PHP1A. Conversely, the frequency of PHP1A in patients presenting CH is dramatically low. This may be due to the low prevalence of PHP1A which remains unknown.
Subclinical and overt hypothyroidism can occur in PHP1A patients at birth many years before PTH resistance becomes clinically apparent. Although such cases appear to be rare, some pediatric patients with unexplained CH are likely to benefit from measuring calcium, phosphorus, and PTH for extended periods of time.
甲状腺功能减退是假性甲状旁腺功能减退症(PHP)中观察到的一种特殊情况,PHP是一种罕见疾病,其特征是甲状旁腺激素(PTH)抵抗,导致低钙血症和高磷血症,与GNAS(鸟嘌呤核苷酸结合蛋白α亚基)突变(PHP1A)或表观突变(PHP1B)相关。为了确定出生时是否存在甲状腺功能减退,我们对我们队列中患有PHP1A(n = 116)或PHP1B(n = 99)的患者进行了一项回顾性研究。我们还调查了出生时患有先天性甲状腺功能减退症(CH)且甲状腺位置正常的患者是否存在提示PTH抵抗和PHP的钙磷异常。我们的研究表明,CH是PHP1A最早的诊断线索,但不是PHP1B的。我们估计,患有PHP1A的患者出生时CH的发生率在8%至34%之间。在PHP1A中,高磷血症和PTH浓度升高先于低钙血症。相反,患有CH的患者中PHP1A的发生率极低。这可能是由于PHP1A的患病率较低,目前尚不清楚。
在PTH抵抗在临床上变得明显之前许多年,PHP1A患者出生时就可能出现亚临床和显性甲状腺功能减退。尽管此类病例似乎很少见,但一些原因不明的CH儿科患者可能会受益于长时间测量钙、磷和PTH。